phase 2_completion
saveShanghai Pulmonary Hospital — undisclosed programmed cell death protein 1 inhibitor (Phase II Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer
Data sources
globaldata
Found something off?
comments(0)
5-min edit window · permanent after that